The objective of the study presented here was to develop either enzymatic or whole cell mediated green procedures for the syntheses of a-hydroxy ketones. Production of optically active synthons is crucial for the preparation of fine chemicals. Enzymes and whole-cell biocatalysts have proven to be excellent vehicles with their chiral nature for the biotransformations. Under the light of this discussion, firstly benzaldehyde lyase [BAL, (EC 4.1.2.38)] was used in novel C-C bond formation reactions to obtain interesting and biologically important precursors / 2-Hydroxy-1-arylethan-1-ones and functionalized aliphatic acyloin derivatives. All the compounds were obtained with high yields and in the case of aliphatic acyloin derivatives with high enantiomeric excesses (ee&rsquo / s). Another strategy was to use whole cell biocatalysis. A.flavus 200120 was found to be a promising biocatalyst with the ability to catalyze a broad range of reactions / reduction, hydrolysis and deracemization, while another fungus / A. oryzae 5048 was utilized in bioreduction reactions of benzil and its derivatives. Each reaction was investigated, optimized and thus enhanced via medium design. Products were obtained with high yields and ee&rsquo / s. To sum up, in this study novel efficient green procedures were developed to synthesize various ahydroxy ketones with high yield and stereoselectivity. These newly established methods present promising alternatives to classical chemical methodologies.

In this study, the aim was to investigate the effects of exponential feeding strategy on benzaldehyde lyase (BAL) production by recombinant Escherichia coli BL21. For this purpose, the effects of medium components were investigated to optimize the initial medium composition of the fed-batch fermentations. For the batch bioreactor operations, the highest cell concentration and BAL activity were achieved in a media containing 30 g L-1 pretreated molasses, and 5 g L-1 (NH4)2HPO4 as 5.07 g L-1, and 1611 U ml-1 at t=8 h, respectively. Thereafter, in order to increase the cell growth and BAL production while avoiding acetate accumulation, fed-batch bioreactor operations were conducted with exponential feeding at different specific growth rates namely, 0.1 h-1 (mu-0.1), 0.15 h-1 (mu-0.15), and 0.2 h-1 (mu-0.2), and a combined exponential and constant feeding (mu-0.2+) strategy. In the experiments, 9 hours of batch-wise operation with the optimized production medium was followed by a fed-batch operation phase using the pre-determined exponential feeding profiles and for mu-0.2+ operation after 10 hours of exponential feeding as mu-0.2, where the feed rate was kept constant at 21.6 g h-1. Additionally, the plasmid stability was investigated using the feeding method of mu-0.2+ operation with antibiotics in the feed solution, and it was observed that the plasmid was stable. Among the three exponential feeding conditions, the highest cell concentration and BAL activity were determined in

<p>This thesis deals with the design and synthesis of chiralenantiopure nitrogencontaining ligands and the use of theseligands in asymmetric catalysis. A modular synthetic approachto enantiopure nitrogen-containing ligands was developed. Thesynthetic method is based on the ring-opening of activatedchiral aziridines by nitrogen nucleophiles. The aziridines areconveniently prepared from amino alcohols. The structure oftheaziridine and of the nucleophile can be extensively varied andlibraries of ligands are easily prepared. The use of primaryamines affords C₂-symmetric bis(sulfonamides), whereas the use ofammonia affords C₃-symmetric tris(sulfonamides) that can beelaborated into the corresponding tetra-amines.</p><p>The C₂- and C₃-symmetric ligands were used in the asymmetrictitaniummediated addition of diethylzinc to benzaldehyderesulting in modest enantioselection, 76% ee. A thoroughinvestigation of the reaction conditions revealed that theamount of Ti(OiPr)₄has a decisive effect on the reaction rate and thestereochemical outcome of the reaction. The reaction timedecreased from about 90 hours to 15 minutes and theenantioselectivity changed from 26% of the (R)- enantiomer to72% of the (S)-enantiomer when the Ti(OiPr)₄:benzaldehyde ratio was increased from 0.125:1 to1.48:1. Moreover, the titanium-mediated addition of diethylzincto benzaldehyde was studied in the presence of chiraladditives. The bis(sulfonamides) were also used in thecyclopropanation of cinnamyl alcohol. However, only lowenantioselection was observed, 27% ee.</p><p>The C₃-symmetric tetra-amines were reacted to formazaphosphatranes. These weak acids were only partiallydeprotonated by the strong base KOtBu to form the correspondingproazaphosphatranes. The unexpectedly strong basicity of theproazaphosphatranes was believed to be due to steric effects assuggested by DFT calculations. The tetra-amines and thesulfonamides were used for the preparation of metal complexesof Lewis acidic metals such as titanium(IV) andzirconium(IV).</p><p><b>Keywords:</b>asymmetric catalysis, aziridine, benzaldehyde,diethylzinc, enantioselective, ligand, proazaphosphatrane,ring-opening, sulfonamide, symmetry, titanium, zirconium</p>

Biphasic systems such as two-phase partitioning bioreactors (TPPBs) have been used to alleviate biological inhibition by sequestering inhibitory compounds within an immiscible phase. The use of solid polymer beads as this auxiliary phase provides a fully biocompatible alternative to commonly used yet potentially toxic organic solvents. This work focused on the application of solid-liquid TPPBs to the bioproduction of the pharmaceutical precursor L-phenylacetylcarbinol (PAC), a biotransformation which suffers from substrate (benzaldehyde), product (PAC), and by-product (benzyl alcohol) inhibition, and simple strategies to improve TPPB performance in general. A wide range of commercially available, biocompatible, and non-bioavailable polymers were screened for their affinity for benzaldehyde, PAC, and benzyl alcohol. Hytrel G3548L demonstrated the highest affinity for all three target compounds and was subsequently used in solid-liquid TPPBs for PAC production. Using 15% v/v polymer beads, PAC concentration was increased by 104% and benzyl alcohol concentration decreased by 38% over the single phase control. The delivery of benzaldehyde from polymer beads demonstrated only a 6-8% reduction in mass productivity with improved operational simplicity and reduced operator intervention. The final objective of this work was to independently investigate various aspects of the aqueous phase composition and determine how each factor affects the partition coefficient of benzaldehyde in Hytrel G3548L. Temperature and pH were observed to have no significant effect on partitioning. Salt and glucose additions increased the partition coefficient by 173% and 30% respectively compared to RO water, while ethanol was found to decrease the partition coefficient from 44 (±1.6) to 1 (±0.3). These findings may be applied to solid-liquid TPPBs to increase or decrease partitioning as required, leading to improved bioreactor performance. This work has successfully shown that with careful polymer selection, solid-liquid TPPBs can be used to increase the productivity of a biotransformation without the associated biocompatibility problems that have sometimes been observed with organic solvents. The delivery of inhibitory substrate from the polymer phase was successfully accomplished, which is a novel demonstration in the field of solid-liquid TPPBs for biocatalysis. Finally this work contributes a range of simple strategies to improve the partitioning behavior of solid-liquid TPPBs using the aqueous phase composition. / Thesis (Master, Chemical Engineering) -- Queen's University, 2010-08-26 10:53:38.569

In this study, the effects of bioprocess operation parameters on benzaldehyde lyase production were systematically investigated. For this purpose, the research program was carried out in mainly four parts. In the first part of the study, Escherichia coli K12 (ATCC 10798), having the highest benzaldehyde lyase production capacity, was selected as the host microorganism. Next, using the selected microorganism, the production medium was designed in terms of its carbon and nitrogen sources. Among the investigated media, the highest cell concentration and benzaldehyde lyase activity were obtained as 1.8 kg m-3 and 745 U cm-3, respectively, in the medium containing 8.0 kg m-3 glucose, 5.0 kg m-3 (NH4)2HPO4 and the salt solution. Thereafter, by using the designed medium, the effects of bioreactor operation parameters, i.e., oxygen transfer and pH, were investigated in pilot scale bioreactor. Oxygen transfer effects on benzaldehyde lyase production were investigated at QO/VR=0.5 vvm / N=250, 375, 500, 625, 750 min-1 and at QO/VR=0.7 vvm, N=750 min-1 conditions. The highest cell concentration and benzaldehyde lyase activity were obtained at 0.5 vvm, 500 min-1 condition as 2.3 kg m-3 and 860 U cm-3, respectively. Finally, the effect of pH was investigated for benzaldehyde lyase production process at Qo/VR=0.5 vvm, N=500 min-1 condition, at pHC=5.0, 6.4, 6.7, 7.0, 7.2 and 7.8 values. Among the investigated pH values, the highest cell concentration and enzyme activity were obtained at pHC=7.0 condition as 2.1 kg m-3 / 775 U cm-3. However, the values obtained at this condition, were lower than the values obtained at pHUC=7.2 uncontrolled pH operation. Hence, medium oxygen transfer condition and uncontrolled pH operation are found to be favorable for benzaldehyde lyase production.

In this study, the benzaldehyde lyase (BAL, EC 4.1.2.38) production in E. coli BL21 (DE3) pLySs as intracellular and in Bacillus species as extracellular were investigated, and comparison of the production capacity of the enzyme in the developed recombinant microorganisms were compared. For this purpose, firstly, PCR amplified bal gene was cloned into pRSETA vector which is under the control of strong T7 promoter and expressed in E. coli BL21 (DE3) pLysS strain. With developed recombinant E. coli BL21 (DE3) pLySs cells, the effect of bioprocess parameters was systematically investigated. Among the investigated media, the highest cell concentration and benzaldehyde lyase activity were obtained as 2.0 kg m-3 and 1060 U cm-3, respectively, in the medium containing 20.0 kg m-3 glucose, 11.8 kg m-3 (NH4)2HPO4 and the salt solution. Thereafter, oxygen transfer effects on benzaldehyde lyase production were investigated at air inlet v rate of QO/VR = 0.5 vvm, and agitation rates of N=500 and 750 min-1 and at QO/VR = 0.7 vvm, N=750 min-1 in pilot scale bioreactor and the highest cell concentration and volumetric BAL activity were found as 1.7 kg m-3 and 990 U cm-3, respectively, at 0.5 vvm, 750 min-1 condition. Next, the signal DNA sequence of serine alkaline protease (SAP) from B. licheniformis DSM 1969 chromosomal DNA (pre-subC) was fused in front of the bal by using PCR-based gene splicing by overlap extension (SOE) method. The fusion product of hybrid gene first cloned into pUC19 plasmid, thereafter sub-cloned into pBR374 shuttle vector and recombinant plasmid was transferred into various Bacillus species. However, no extracellular production of benzaldehyde lyase was observed in none of the developed recombinant Bacillus species, probably because of ineffective secretion system, inefficient folding of heterologous protein, degradation of enzyme due to proteolytic activity or high inactivation rate of the enzyme.

Thesis (M.S.)--Florida State University, 2005. / Advisor: Dr. Marie E. Krafft, Florida State University, College of Arts and Sciences, Dept. of Chemistry and Biochemistry. Title and description from dissertation home page (viewed Sept. 19, 2005). Document formatted into pages; contains 147 pages. Includes bibliographical references.

Objetivos: Avaliar a farmacocinética e a distribuição tecidual do benzaldeído semicarbazona livre (BS) e incluso em ß-Ciclodextrinas (BS/ß-CD) após administração de diversas doses por diferentes vias de administração. Metodologia: As concentrações plasmáticas de BS foram quantificadas através de método analítico por CLAE-UV desenvolvido e validado, após administração das doses de 10 mg/kg i.v. bolus e 50 e 100 mg/kg p.o. da droga livre e 10 mg/kg i.v. bolus e 50 mg/kg p.o. da droga complexada a ratos Wistar (n = 8 animais/grupo). Os perfis plasmáticos foram avaliados individualmente pelas abordagens não-compartimental e compartimental para determinação dos parâmetros farmacocinéticos. A avaliação compartimental foi realizada utilizando software Scientist 2.0.1 (Micromath®). A ligação do BS a proteínas plasmáticas foi determinada por ultrafiltração na faixa de 1,0 a 60,0 µg/mL. O perfil de penetração tecidual da droga livre e complexada foi investigado em diferentes órgãos utilizando o método de homogeneizado de tecido até 5 h após administração de dose 10 mg/kg i.v. A penetração cerebral também foi avaliada para a droga livre e inclusa em ß-CD após a dose de 50 mg/kg até 4 h após administração (n = 3 animais/tempo coleta). Resultados e Discussão: A fração livre do BS em plasma de ratos foi de 34 ± 5%. O modelo de um compartimento descreveu adequadamente todos os perfis plasmáticos estudados. Após doses intravenosa (10 mg/kg) e oral (50 mg/kg), parâmetros farmacocinéticos como Vd (1,6 ± 0,5 e 2,2 ± 0,8 L/kg, respectivamente) e Cltot (1,4 ± 0,5 and 1,8 ± 0,5 L/h×kg, respectivamente) foram maiores para o BS complexado em relação à droga livre, embora os t1/2 (0,8 ± 0,1 h-1) mantiveram-se similares (p < 0,05). A biodisponibilidade oral do BS/ß-CD (~37%) foi aproximadamente o dobro daquela observada para a droga livre (~20%). O fator de penetração cerebral após doses intravenosa (2,8) e oral (2,5), assim como tempo de residência médio, foram maiores para a droga complexada, independente da via de administração avaliada. Conclusões: A farmacocinética do BS livre e complexado mostra uma rápida distribuição tecidual e uma rápida eliminação. A maior penetração cerebral do complexo em relação à droga livre mostra que a ß-CD é uma estrutura capaz de vetorizar, reter e modificar a liberação do BS nesse órgão, explicando os achados farmacodinâmicos prévios. / Purpose: This study aimed to investigate the pharmacokinetics and tissue distribution of benzaldehyde semicarbazone (BS) free and complexed with ß- cyclodextrin (BS/ß-CD) after administration to rodents at different doses by diverse routes. Methodology: BS plasma concentrations were determinated in Wistar rats after administration of 10 mg/kg i.v bolus and 50 and 100 mg/kg p.o. for the free drug and 10 mg/kg i.v. bolus and 50 mg/kg for the BS/ß-CD (n = 8/group), using a HPLCUV method specifically developed and validated. Individual plasma profiles obtained were evaluated by non-compartmental and compartmental approaches, using the software Scientist 2.0.1 (MicroMath®), analysis to determine the pharmacokinetic parameters. BS protein binding was determined by ultrafiltration at a concentration range of 1.0 a 60.0 µg/mL. BS tissue penetration after free or ß-CD-complexed drug administration was investigated in different tissues homogenates up to 5 h after i.v. bolus dosing of 10 mg/kg dose. Brain penetration of the free and complexed drug was also evaluated up to 4 h after administration of 50 mg/kg p.o. dose (3 animals/time point). Results and Discussion: BS free fraction in plasma was 34 ± 5%. The one-compartmental model described adequately the plasma profiles of all groups investigated. After i.v. (10 mg/kg) and p.o. (50 mg/kg) doses, pharmacokinetic parameters such as Vd (1.6 ± 0.5 e 2.2 ± 0.8 L/kg, respectively) and CLtot (1.4 ± 0.5 and 1.8 ± 0.5 L/h×kg, respectively) were higher for the BS/ß-CD than for the free drug, although the t1/2 (0.8 ± 0.1 h-1) remained the same (p < 0.05). The oral bioavailability of the BS/ß-CD (~ 37%) was approximately 2-fold of that observed for the free BS (~ 20%). The brain penetration factor after i.v. (2.8) and p.o. (2.5) doses, as well as the mean residence time, were higher after BS/ß-CD dosing than after free drug dosing, regardless of the route administrated. Conclusions: BS pharmacokinetics (free and complexed) showed a fast tissue distribution and elimination. The higher brain penetration of the drug after the administration of the complex reveals that the ß-CD may be a potential system to carrier, retain and change the delivery of BS in this organ, explaining the previous pharmacodynamic results.

Objetivos: Avaliar a farmacocinética e a distribuição tecidual do benzaldeído semicarbazona livre (BS) e incluso em ß-Ciclodextrinas (BS/ß-CD) após administração de diversas doses por diferentes vias de administração. Metodologia: As concentrações plasmáticas de BS foram quantificadas através de método analítico por CLAE-UV desenvolvido e validado, após administração das doses de 10 mg/kg i.v. bolus e 50 e 100 mg/kg p.o. da droga livre e 10 mg/kg i.v. bolus e 50 mg/kg p.o. da droga complexada a ratos Wistar (n = 8 animais/grupo). Os perfis plasmáticos foram avaliados individualmente pelas abordagens não-compartimental e compartimental para determinação dos parâmetros farmacocinéticos. A avaliação compartimental foi realizada utilizando software Scientist 2.0.1 (Micromath®). A ligação do BS a proteínas plasmáticas foi determinada por ultrafiltração na faixa de 1,0 a 60,0 µg/mL. O perfil de penetração tecidual da droga livre e complexada foi investigado em diferentes órgãos utilizando o método de homogeneizado de tecido até 5 h após administração de dose 10 mg/kg i.v. A penetração cerebral também foi avaliada para a droga livre e inclusa em ß-CD após a dose de 50 mg/kg até 4 h após administração (n = 3 animais/tempo coleta). Resultados e Discussão: A fração livre do BS em plasma de ratos foi de 34 ± 5%. O modelo de um compartimento descreveu adequadamente todos os perfis plasmáticos estudados. Após doses intravenosa (10 mg/kg) e oral (50 mg/kg), parâmetros farmacocinéticos como Vd (1,6 ± 0,5 e 2,2 ± 0,8 L/kg, respectivamente) e Cltot (1,4 ± 0,5 and 1,8 ± 0,5 L/h×kg, respectivamente) foram maiores para o BS complexado em relação à droga livre, embora os t1/2 (0,8 ± 0,1 h-1) mantiveram-se similares (p < 0,05). A biodisponibilidade oral do BS/ß-CD (~37%) foi aproximadamente o dobro daquela observada para a droga livre (~20%). O fator de penetração cerebral após doses intravenosa (2,8) e oral (2,5), assim como tempo de residência médio, foram maiores para a droga complexada, independente da via de administração avaliada. Conclusões: A farmacocinética do BS livre e complexado mostra uma rápida distribuição tecidual e uma rápida eliminação. A maior penetração cerebral do complexo em relação à droga livre mostra que a ß-CD é uma estrutura capaz de vetorizar, reter e modificar a liberação do BS nesse órgão, explicando os achados farmacodinâmicos prévios. / Purpose: This study aimed to investigate the pharmacokinetics and tissue distribution of benzaldehyde semicarbazone (BS) free and complexed with ß- cyclodextrin (BS/ß-CD) after administration to rodents at different doses by diverse routes. Methodology: BS plasma concentrations were determinated in Wistar rats after administration of 10 mg/kg i.v bolus and 50 and 100 mg/kg p.o. for the free drug and 10 mg/kg i.v. bolus and 50 mg/kg for the BS/ß-CD (n = 8/group), using a HPLCUV method specifically developed and validated. Individual plasma profiles obtained were evaluated by non-compartmental and compartmental approaches, using the software Scientist 2.0.1 (MicroMath®), analysis to determine the pharmacokinetic parameters. BS protein binding was determined by ultrafiltration at a concentration range of 1.0 a 60.0 µg/mL. BS tissue penetration after free or ß-CD-complexed drug administration was investigated in different tissues homogenates up to 5 h after i.v. bolus dosing of 10 mg/kg dose. Brain penetration of the free and complexed drug was also evaluated up to 4 h after administration of 50 mg/kg p.o. dose (3 animals/time point). Results and Discussion: BS free fraction in plasma was 34 ± 5%. The one-compartmental model described adequately the plasma profiles of all groups investigated. After i.v. (10 mg/kg) and p.o. (50 mg/kg) doses, pharmacokinetic parameters such as Vd (1.6 ± 0.5 e 2.2 ± 0.8 L/kg, respectively) and CLtot (1.4 ± 0.5 and 1.8 ± 0.5 L/h×kg, respectively) were higher for the BS/ß-CD than for the free drug, although the t1/2 (0.8 ± 0.1 h-1) remained the same (p < 0.05). The oral bioavailability of the BS/ß-CD (~ 37%) was approximately 2-fold of that observed for the free BS (~ 20%). The brain penetration factor after i.v. (2.8) and p.o. (2.5) doses, as well as the mean residence time, were higher after BS/ß-CD dosing than after free drug dosing, regardless of the route administrated. Conclusions: BS pharmacokinetics (free and complexed) showed a fast tissue distribution and elimination. The higher brain penetration of the drug after the administration of the complex reveals that the ß-CD may be a potential system to carrier, retain and change the delivery of BS in this organ, explaining the previous pharmacodynamic results.

Objetivos: Avaliar a farmacocinética e a distribuição tecidual do benzaldeído semicarbazona livre (BS) e incluso em ß-Ciclodextrinas (BS/ß-CD) após administração de diversas doses por diferentes vias de administração. Metodologia: As concentrações plasmáticas de BS foram quantificadas através de método analítico por CLAE-UV desenvolvido e validado, após administração das doses de 10 mg/kg i.v. bolus e 50 e 100 mg/kg p.o. da droga livre e 10 mg/kg i.v. bolus e 50 mg/kg p.o. da droga complexada a ratos Wistar (n = 8 animais/grupo). Os perfis plasmáticos foram avaliados individualmente pelas abordagens não-compartimental e compartimental para determinação dos parâmetros farmacocinéticos. A avaliação compartimental foi realizada utilizando software Scientist 2.0.1 (Micromath®). A ligação do BS a proteínas plasmáticas foi determinada por ultrafiltração na faixa de 1,0 a 60,0 µg/mL. O perfil de penetração tecidual da droga livre e complexada foi investigado em diferentes órgãos utilizando o método de homogeneizado de tecido até 5 h após administração de dose 10 mg/kg i.v. A penetração cerebral também foi avaliada para a droga livre e inclusa em ß-CD após a dose de 50 mg/kg até 4 h após administração (n = 3 animais/tempo coleta). Resultados e Discussão: A fração livre do BS em plasma de ratos foi de 34 ± 5%. O modelo de um compartimento descreveu adequadamente todos os perfis plasmáticos estudados. Após doses intravenosa (10 mg/kg) e oral (50 mg/kg), parâmetros farmacocinéticos como Vd (1,6 ± 0,5 e 2,2 ± 0,8 L/kg, respectivamente) e Cltot (1,4 ± 0,5 and 1,8 ± 0,5 L/h×kg, respectivamente) foram maiores para o BS complexado em relação à droga livre, embora os t1/2 (0,8 ± 0,1 h-1) mantiveram-se similares (p < 0,05). A biodisponibilidade oral do BS/ß-CD (~37%) foi aproximadamente o dobro daquela observada para a droga livre (~20%). O fator de penetração cerebral após doses intravenosa (2,8) e oral (2,5), assim como tempo de residência médio, foram maiores para a droga complexada, independente da via de administração avaliada. Conclusões: A farmacocinética do BS livre e complexado mostra uma rápida distribuição tecidual e uma rápida eliminação. A maior penetração cerebral do complexo em relação à droga livre mostra que a ß-CD é uma estrutura capaz de vetorizar, reter e modificar a liberação do BS nesse órgão, explicando os achados farmacodinâmicos prévios. / Purpose: This study aimed to investigate the pharmacokinetics and tissue distribution of benzaldehyde semicarbazone (BS) free and complexed with ß- cyclodextrin (BS/ß-CD) after administration to rodents at different doses by diverse routes. Methodology: BS plasma concentrations were determinated in Wistar rats after administration of 10 mg/kg i.v bolus and 50 and 100 mg/kg p.o. for the free drug and 10 mg/kg i.v. bolus and 50 mg/kg for the BS/ß-CD (n = 8/group), using a HPLCUV method specifically developed and validated. Individual plasma profiles obtained were evaluated by non-compartmental and compartmental approaches, using the software Scientist 2.0.1 (MicroMath®), analysis to determine the pharmacokinetic parameters. BS protein binding was determined by ultrafiltration at a concentration range of 1.0 a 60.0 µg/mL. BS tissue penetration after free or ß-CD-complexed drug administration was investigated in different tissues homogenates up to 5 h after i.v. bolus dosing of 10 mg/kg dose. Brain penetration of the free and complexed drug was also evaluated up to 4 h after administration of 50 mg/kg p.o. dose (3 animals/time point). Results and Discussion: BS free fraction in plasma was 34 ± 5%. The one-compartmental model described adequately the plasma profiles of all groups investigated. After i.v. (10 mg/kg) and p.o. (50 mg/kg) doses, pharmacokinetic parameters such as Vd (1.6 ± 0.5 e 2.2 ± 0.8 L/kg, respectively) and CLtot (1.4 ± 0.5 and 1.8 ± 0.5 L/h×kg, respectively) were higher for the BS/ß-CD than for the free drug, although the t1/2 (0.8 ± 0.1 h-1) remained the same (p < 0.05). The oral bioavailability of the BS/ß-CD (~ 37%) was approximately 2-fold of that observed for the free BS (~ 20%). The brain penetration factor after i.v. (2.8) and p.o. (2.5) doses, as well as the mean residence time, were higher after BS/ß-CD dosing than after free drug dosing, regardless of the route administrated. Conclusions: BS pharmacokinetics (free and complexed) showed a fast tissue distribution and elimination. The higher brain penetration of the drug after the administration of the complex reveals that the ß-CD may be a potential system to carrier, retain and change the delivery of BS in this organ, explaining the previous pharmacodynamic results.